Pacira BioSciences' Inventory Average rose 42.05% to $152.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $152.9 million, marking a year-over-year increase of 42.05%. This contributed to the annual value of $114.8 million for FY2024, which is 14.58% up from last year.
As of Q3 2025, Pacira BioSciences' Inventory Average stood at $152.9 million, which was up 8.49% from $141.0 million recorded in Q2 2025.
In the past 5 years, Pacira BioSciences' Inventory Average registered a high of $152.9 million during Q3 2025, and its lowest value of $64.6 million during Q1 2021.
Over the past 3 years, Pacira BioSciences' median Inventory Average value was $100.6 million (recorded in 2024), while the average stood at $112.0 million.
In the last 5 years, Pacira BioSciences' Inventory Average soared by 57.27% in 2022 and then declined by 9.37% in 2023.
Quarterly analysis of 5 years shows Pacira BioSciences' Inventory Average stood at $82.9 million in 2021, then rose by 16.35% to $96.4 million in 2022, then climbed by 4.15% to $100.4 million in 2023, then rose by 18.06% to $118.6 million in 2024, then skyrocketed by 42.05% to $152.9 million in 2025.
Its last three reported values are $152.9 million in Q3 2025, $141.0 million for Q2 2025, and $129.5 million during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value